ED Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Consolidated Edison is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading around fair value near key support, but the analyst community is mixed-to-negative, the short-term price trend is weak, and the expected near-term downside pattern is not attractive for an impatient buyer. I would hold off rather than buy immediately.
ED closed at 106, slightly below the previous close of 106.3, with the regular session down 1.58%. The technical picture is mixed: MACD histogram is positive but contracting, RSI_6 at 40.87 is neutral-to-weak, and the moving averages remain bullish with SMA_5 > SMA_20 > SMA_200. Price is sitting near support at 105.73, with resistance at 107.23 and 108.73. Overall, the trend is not strongly bearish, but momentum is soft and upside follow-through is limited.
Hedge funds have been buying aggressively, with buying up 108.15% over the last quarter. Utilities are also benefiting from constructive sector sentiment and ongoing system investment, which should support regulated earnings growth over time.
Recent analyst sentiment is mostly cautious to negative, with multiple Underweight/Underperform/Sell ratings and several price targets clustered around or below the current price. The stock trend model suggests weak forward performance, including a negative one-month expectation. There is no AI Stock Picker or SwingMax signal today, and there is no recent congress trading data or notable politician buying to provide a fresh catalyst. The latest news is generally supportive of dividend stability but not a strong near-term growth trigger.
The latest quarter financial snapshot was unavailable due to a data error, so I cannot assess the most recent quarter in detail. From the available news, the company reported over $2 billion in net income for 2025, which supports steady utility-grade profitability and dividend coverage. For a long-term investor, this points to stability rather than rapid growth.
Analyst ratings have trended cautiously negative. Goldman Sachs set a Sell rating with a $105 target, Barclays has Underweight with a $107 target, BofA has Underperform with a $107 target, and several firms remain In Line or Equal Weight. Even bullish-leaning targets are mostly near the current price, which suggests limited upside. Wall Street’s view is broadly split, but the practical consensus is that ED is a defensive income name rather than an attractive buy at this level.
